Pfizer launches biosimilar Rituxan trial in RA [Does anyone know whether PF-05280586 was developed in house or licensed from someone else? Thanks.] http://www.biocentury.com/dailynews/company/2012-05-08/pfizer-launches-biosimilar-rituxan-trial